Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic mela... von Samoylenko, Igor V., Demidov, Lev V., Moiseenko, Fedor V., Dvorkin, Mikhail V., Demidova, Svetlana A., Protsenko, Svetlana A., Stroyakovskiy, Daniil L., Kozlov, Vadim V., Odintsova, Svetlana V., Kirtbaya, Dmitry V., Tantsyrev, Denis A., Mochalova, Anastasia S., Orlova, Rashida V., Mukhametshina, Guzel Z., Fadeeva, Natalia V., Fomin, Evgeny A., Chapko, Yana S., Tarasova, Anna V., Ermakov, Nikolay B., Shemerovskiy, Alexander K., Vaschenko, Vera A., Chistyakov, Valery M., Zinkina-Orikhan, Arina V., Lin'kova, Yulia N., Kryukov, Fedor B., Sorokina, Irina V., Siliutina, Anna A.

Volltext

Defendor: Real-world evidence of primary prolonged G-CSF prophylaxis by empegfilgrastim for relative dose intensity compliance in patients with solid tumors—The primary analysis von Snegovoy, Anton, Dergunov, Alexander, Tatyanenko, Anna, Yakuba, Darya, Elkova, Viktoriya, Shalina, Anna, Komoza, Yulia, Dmitrochenko, Marina, Soroka, Svetlana, Shegurova, Margarita, Chapko, Yana, Dmitriev, Vadim, Timin, Vladimir, Rossokha, Elena, Gronskaya, Yulia, Kononenko, Inessa, Sorokina, Irina

Volltext